Top Image
Advanced Centre for Treatment Research & Education in Cancer
Facebook Twitter Gmail
Banner Image
Science Sparks @ ACTREC
Date Image 29th April 2024 Vol. No. 13 ; Issue No.628
Publications

1. Moharir S, Khobragade P, Rane R, Suryawanshi M, Pal K, Gawade B, Kumar D, Satpute B (2024). Discovery of novel diesters incorporating Kojic acid with NSAIDs and Palmitic acid as dual inhibitor of melanogenesis and inflammation. Journal of Pharmaceutical Sciences.

2. Charnalia M, Chopra S, Mulani J, Popat P, Rath S, Thomeer M, Mittal P, Gupta A, Boere I, Gupta S, Nout RA (2024). RECIST 1.1 versus clinico-radiological response assessment for locally advanced cervical cancer: implications on interpreting survival outcomes of future trials. International Journal of Gynecological Cancer.

Site of the Week

OpenNeuro is a free and open platform that shares images pertaining to MRI, MEG, EEG, iEEG, ECoG, ASL, and PET data.

desktop Image
Interesting Reads

Perurena N, Situ L, Cichowski K (2024). Combinatorial strategies to target RAS-driven cancers. Nature Reviews Cancer.

Video of the Week
Functional Cancer Proteomics and Signalling Architecture in Breast Cancer.
Upcoming Events
Deciphering Tumor Ecosystems in Space and Time

June 9-14, 2024

At Southern New Hampshire University, USA

5th International Conference on Innate Lymphoid Cells

July 15-17, 2024,

At Cambridge, UK

Cancer and Diagnostics

July 11-12, 2024

At Vancouver, Canada

Do You Know?

In 1845, John Hughes Bennett, the Edinburgh physician, was the first to describe leukemia as an excessive proliferation of blood cells.

back Image
Cancer News
Approval of elahere expands treatment options for some advanced ovarian cancers.

National Cancer Institute, 24/04/2024

The FDA approval was based on the results of a large randomized clinical trial called MIRASOL. Results showed that people with FR-α-positive, platinum-resistant ovarian tumors who were treated with Elahere lived longer overall than people treated with standard chemotherapy...

Targeting specific protein regions offers a new treatment approach in medulloblastoma

MedicalXpress, 25/04/2024

The researchers identified inhibitors that can interact with either of two specific regions of EP300/CBP: the histone acetyltransferase (HAT) domain and the bromodomain. Using high-throughput cell line–based screening, the team tested these region-specific inhibitors across over 400 different cancer cell lines...

Discovering cancers of epigenetic origin without DNA mutation

ScienceDaily, 24/04/2024

A research team has discovered that cancer, one of the leading causes of death worldwide, can be caused entirely by epigenetic changes, in other words, changes that contribute to how gene expression is regulated, and partly explain why, despite an identical genome...

2019 Advanced Centre for Treatment, Research and Education in Cancer (ACTREC)